×

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Chapters (5)
Description
Date : Tuesday, February 20th 2018 from 12:30pm to 02pm (GMT+2)
Honolulu : Tuesday, February 20th 2018 from 12:30am to 02am (GMT-10)
San Francisco : Tuesday, February 20th 2018 from 02:30am to 04am (GMT-8)
New York : Tuesday, February 20th 2018 from 05:30am to 07am (GMT-5)
Buenos Aires : Tuesday, February 20th 2018 from 07:30am to 09am (GMT-3)
London / Dublin : Tuesday, February 20th 2018 from 10:30am to 12pm (GMT)
Paris / Berlin : Tuesday, February 20th 2018 from 11:30am to 01pm (GMT+1)
Istanbul : Tuesday, February 20th 2018 from 12:30pm to 02pm (GMT+2)
Moscou / Dubaï : Tuesday, February 20th 2018 from 02:30pm to 04pm (GMT+4)
Bangkok : Tuesday, February 20th 2018 from 05:30pm to 07pm (GMT+7)
Shanghai : Tuesday, February 20th 2018 from 06:30pm to 08pm (GMT+8)
Tokyo : Tuesday, February 20th 2018 from 07:30pm to 09pm (GMT+9)
Sydney : Tuesday, February 20th 2018 from 08:30pm to 10pm (GMT+10)
Wellington : Tuesday, February 20th 2018 from 10:30pm to 12am (GMT+12)
Last update : 2018-03-10
Language(s) : English

Please give us your feedback after the live

Fill the survey →

Through an interactive discussion around video cases performed by expert operators, find out how reknown experts challenge each other on their usage of Drug Eluting Technologies in the SFA.
Live webinar in direct from Paris "Boston Scientific Institute for Advancing Science".
 

Program

  • What's next in DET?
    Interactive Experts discussion 
     
  • Take home messages

Educational objectives

  • Discuss current trends and approaches to the treatment of SFA lesions with the use of DES and DCB in long lesions, in terms of patient’s outcomes.
  • Learn and observe a step-by-step complex procedure with technical and strategical tips & tricks.
  • How to choose your strategy depending on clinical, anatomical and cost efficiency criteria.
  • Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease.
  • Provide platform for discussion and mutual learning with your experts.

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists).
  • Referring physicians of patients with peripheral artery disease.
Linked playlists (2)
Comments(1)
Join the Discussion
  • Obiora A. excellent work

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Comment with Facebook

    September 2015
    Honolulu : Thursday, September 24th 2015 from 05am to 06am (GMT-10)
    San Francisco : Thursday, September 24th 2015 from 08am to 09am (GMT-7)
    New York : Thursday, September 24th 2015 from 11am to 12pm (GMT-4)
    Buenos Aires : Thursday, September 24th 2015 from 12pm to 01pm (GMT-3)
    Reykjavik : Thursday, September 24th 2015 from 03pm to 04pm (GMT)
    London / Dublin : Thursday, September 24th 2015 from 04pm to 05pm (GMT+1)
    Paris / Berlin : Thursday, September 24th 2015 from 05pm to 06pm (GMT+2)
    Istanbul : Thursday, September 24th 2015 from 06pm to 07pm (GMT+3)
    Moscou / Dubaï : Thursday, September 24th 2015 from 07pm to 08pm (GMT+4)
    Bangkok : Thursday, September 24th 2015 from 10pm to 11pm (GMT+7)
    Shanghai : Thursday, September 24th 2015 from 11pm to 12am (GMT+8)
    Tokyo : Friday, September 25th 2015 from 12am to 01am (GMT+9)
    Sydney : Friday, September 25th 2015 from 02am to 03am (GMT+11)
    Wellington : Friday, September 25th 2015 from 04am to 05am (GMT+13)

    Complex femoro-popliteal interventions

    What are the limits?

    Share
    Scroll Up